CommercialCoverageMedium impact
06.02.56i, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
IBX Commercial has reissued policy 06.02.56i regarding noninvasive techniques for evaluating and monitoring chronic liver disease patients. This is a policy reissuance with an effective date of October 1, 2025, but specific changes are not detailed in the summary provided.
Action Required
By October 1, 2025: Billing team should review the complete policy document at the IBX website to understand any changes to coverage criteria, prior authorization requirements, or billing guidelines for noninvasive liver monitoring techniques. Update billing procedures and staff training as needed based on the full policy content.